Details for 2024724715
Up to date per 26.04.2026
Actions
Details for 2024724715
Granted/Registered
European Patent
18.06.2025 A
01.04.2026 B1
07.04.2023
US
202363495049 P
12.07.2023
US
202363526362 P
29.12.2023
US
202363615985 P
A61K 31/351 20060101AFI20250911BHEP
Owner
Terns Pharmaceuticals, Inc.1065 East Hillsdale Blvd. Suite 100 Foster City, California 94404US
Representative
No representatives present
Inventor
TEAL, Olivia D. Foster City, California 94404US
QUINN, Kevin P. Foster City, California 94404US
JONES, Christopher T. Foster City, California 94404US
JASPER, Jeffrey R. Foster City, California 94404US
Information about Fees